Global ESR Analyzers Market - 2023-2030

Global ESR Analyzers Market - 2023-2030

Global ESR analyzers market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.

The erythrocyte sedimentation rate analyzers which is also known as the ESR analyzers, are the medical devices used for a clinical lab test that measures the rate at which red blood cells in whole blood descend into a standardized tube, reported as mm per hour. This test is used to measure inflammation as inflamed red blood cells settle quickly relative to normal blood cells. A high ESR can be indicative of elevated inflammation, though other conditions such as anemia, renal failure, and obesity can increase the ESR rate as well.

If an ESR test shows that the red blood cells sink faster than normal, it means that the medical condition causing inflammation. The speed of the test result is based on inflammation. Faster ESR rates mean higher levels of inflammation. However, an ESR test alone cannot diagnose what condition is causing the inflammation. An ESR test can be used with other tests to help diagnose conditions that cause inflammation. These analyzers are used to diagnose many types of conditions that cause inflammation, including arthritis, vasculitis, infection and inflammatory bowel disease. ESR analyzers also be used to monitor an existing condition.

Market Dynamics: Drivers

Increasing adoption of advanced ESR analyzers

The increasing adoption of advanced ESR analyzers is expected to drive the market over the forecast period. These advanced ESR analyzers typically offer higher levels of accuracy and precision in ESR testing and measurements. This is very crucial for the accurate diagnosis and monitoring of various medical conditions such as various types of inflammatory diseases. Thus, these advanced analyzers are more prone to be adopted for various medical conditions.

For instance, on March 14, 2022, Mindray, a global leading medical solution provider, launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.

In addition, many advanced ESR analyzers are usually automated and can provide results more quickly. This can lead to quicker diagnosis and treatment decisions, which is especially important in critical conditions. Advanced ESR analyzers are known to have higher throughput capabilities by allowing clinical laboratories to process a larger volume of tests more efficiently.

For instance, on May 20, 2022, Transasia Bio-Medicals Ltd launched two new products in its growing portfolio of in vitro diagnostics, Erba XL 640 and ESL 30. In its ESR portfolio, Transasia announced the launch of ESL 30, a truly automated ESR analyzer system with a touchscreen interface that improves workflow, turnaround time and laboratory safety.

Further, the increasing prevalence of inflammation disorders, rising FDA approvals for the more advanced ESR analyzers, increasing awareness about the advantages of the ESR analyzers and technological advancements in ESR analyzers are expected to drive the market over the forecast period.

Restraints

Factors such as complications associated with the ESR analyzers, the high cost of the ESR analyzers, these analyzers requiring a large volume of sodium citrate and high testing time that is it requires at least 1 hour of testing time are the factors expected to hamper the market over the forecast period.

Segment Analysis

The global ESR analyzers market is segmented based on product type, method, application, end-user and region.

The automated ESR analyzer segment accounted for approximately 47.4% of the ESR analyzers market share

The automated ESR analyzer segment is expected to hold the largest market share over the forecast period. Automated ESR analyzers are very well known for their higher accuracy and precision especially in ESR measurements compared to other semi-automated and manual methods. This is crucial for reliable, rapid and accurate test results, which are important for diagnostic purposes.

For instance, on December 21, 2020, Nihon Kohden launched MEK-1305 Celltac α+, an Automated Hematology and ESR Analyzer. MEK-1305 is the world’s first hematology analyzer that can measure complete blood count (CBC) including white blood cell 3-part differential and erythrocyte sedimentation rate (ESR) simultaneously. The Company developed MEK-1305 based on the concept of providing rapid and accurate test results, which are important for understanding the clinical condition of patients.

Moreover, these automated ESR analyzers are specifically designed to perform ESR tests quickly and more efficiently by saving time. Automated ESR analyzers minimize the variability, where factors like tube size, tilt angle, and room temperature can affect results. These analyzers often have a higher throughput capacity, allowing laboratories to process a larger volume of samples in a shorter time. In addition, their wide adoption also increases the demand for automated ESR analyzers.

Geographical Analysis

North America accounted for approximately 41.2% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing demand for ESR analyzers in the region. North America especially the United States is known for its strong presence of major players such as medical device companies which mainly focus on the development of more advanced ESR analyzers that provide rapid and accurate test results.

In addition, there is a continuously increasing demand for ESR analyzers, which is expected to drive the market in the region. The ESR analyzers are most commonly used in the diagnosis of giant cell arteritis. There is an increasing prevalence of giant cell arteritis in the United States, which increases the demand for ESR analyzers for better, rapid and accurate test results, this further driving the market in the region.

For instance, according to the National Institute of Health (NIH), the annual incidence of Giant cell arteritis (GCA) in the US is estimated to be 18.9 per 100,000, and the estimated prevalence is 228 per 100,000. It is estimated that nearly 950,000 individuals will be diagnosed with GCA and 140,000 will become visually impaired because of GCA in the US upto 2050.

Competitive Landscape

The major global players in the ESR analyzers market include Cardinal Health, Inc., Medsource Ozone Biomedicals Pvt. Ltd., Labtron Equipment Ltd., Carolina Liquid Chemistries Corp., Thermo Fisher Scientific Inc., Zimed Healthcare Inc., ALCOR Scientific Inc., Alifax S.r.l., Q-line Biotech Pvt Ltd. and Caretium Medical Instruments Co. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global ESR analyzers market. During the pandemic, there is an increased need for diagnostic equipment including ESR analyzers, which positively impacted the market. In COVID-19 situations, there is an increased requirement for more diagnostic tools like ESR analyzers to cope with the influx of COVID-19 patients and the need to monitor many inflammatory conditions. The pandemic also disrupted the supply chain of these devices globally.

Market Segmentation

By Product Type
• Automated ESR Analyzer
• Semi-Automated ESR Analyzer
• Manual ESR Analyzer

By Method
• Westergren Method
• Wintrobe Method

By Application
• Giant Cell Arteritis
• Polymyalgia Rheumatica
• Rheumatoid Arthritis
• Tuberculosis
• Systemic Lupus Erythematosus
• Others

By End-User
• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?
• To visualize the global ESR analyzers market segmentation based on product type, method, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of ESR analyzers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global ESR analyzers market report would provide approximately 69 tables, 70 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies